AMA Issues Practice Reopening Checklist for Physicians

As cities and states begin to relax stay at home orders and allow nonessential businesses to reopen, the American Medical Association (AMA) has published a Physician Guide to Reopening Practices. It includes guidance on advance planning for incremental reopening, legal and insurance coverage considerations, and the institution of safety measures for both patients and staff.

REVIAN Red Wins MedTech Breakthrough Technology Award

The REVIAN RED hair growth system from medical technology company REVIAN was recognized as the “Best New Dermatology Technology Solution” at the fourth annual MedTech Breakthrough Awards. MedTech Breakthtough, an independent market intelligence organization, recognizes the top companies, technologies and products in the global health and medical technology market each year.

Revance To Acquire HintMD

Revance Therapeutics, a biotechnology company focused on aesthetic and therapeutic offerings including a next-generation neuromodulator product, DaxibotulinumtoxinA for Injection, has signed a definitive agreement to acquire Hint, a privately held company doing business under the name HintMD, which has created an integrated financial technology (fintech) platform for the aesthetics industry. The transaction is expected to close in the third quarter of 2020, subject to customary closing conditions, including receipt of approval of the requisite HintMD stockholders.

AbbVie Acquires Allergan

Global biopharmaceutical company AbbVie has completed its acquisition of Allergan. The acquisition significantly expands and diversifies AbbVie’s product portfolio, which currently includes Humira, Skyrizi and Rinvoq under its Immunology umbrella, and Hematologic Oncology brands Imbruvica and Venclexta.

Dermatologists Urge Greater Focus on Facial Erythema in Rosacea Patients

Facial erythema and quality of life

New developments in rosacea call for dermatologists to place greater emphasis on addressing persistent facial erythema, according to experts who took part in a recent National Rosacea Society (NRS) roundtable. The goal of the roundtable discussion was to provide an update on this key aspect of the disorder, based on the new standard classification system, recent burden-of-illness study results, new standard management options and significant advances in medical therapy and patient care.

Multidisciplinary Task Force Publishes Guide To Resuming Aesthetic Care

A multidisciplinary panel of physicians and doctoral experts in the fields of infectious disease, immunology, public-health policy, dermatology, facial plastic surgery and plastic surgery came together to develop a set of guiding principles and practices for medical aesthetic facilities as they begin to reopen following the COVID-19 closures.